Literature DB >> 22108804

Gelsolin associates with the N terminus of syntaxin 4 to regulate insulin granule exocytosis.

Michael A Kalwat1, Dean A Wiseman, Wei Luo, Zhanxiang Wang, Debbie C Thurmond.   

Abstract

The plasma membrane soluble N-ethylmaleimide-sensitive factor attachment receptor (SNARE) protein syntaxin (Syn)4 is required for biphasic insulin secretion, although how it regulates each phase remains unclear. In a screen to identify new Syn4-interacting factors, the calcium-activated F-actin-severing protein gelsolin was revealed. Gelsolin has been previously implicated as a positive effector of insulin secretion, although a molecular mechanism to underlie this function is lacking. Toward this, our in vitro binding studies showed the Syn4-gelsolin interaction to be direct and mediated by the N-terminal Ha domain (amino acid residues 39-70) of Syn4. Syn4-gelsolin complexes formed under basal conditions and dissociated upon acute glucose or KCl stimulation; nifedipine blocked dissociation. The dissociating action of secretagogues could be mimicked by expression of the N-terminal Ha domain of Syn4 fused to green fluorescent protein (GFP) (GFP-39-70). Furthermore, GFP-39-70 expression in isolated mouse islet and clonal MIN6 β-cells initiated insulin release in the absence of appropriate stimuli. Consistent with this, the inhibitory GFP-39-70 peptide also initiated Syn4 activation in the absence of stimuli. Moreover, although MIN6 β-cells expressing the GFP-39-70 peptide maintained normal calcium influx in response to KCl, KCl-stimulated insulin secretion and the triggering pathway of insulin secretion were significantly impaired. Taken together, these data support a mechanistic model for gelsolin's role in insulin exocytosis: gelsolin clamps unsolicited soluble N-ethylmaleimide-sensitive factor attachment receptor (SNARE)-regulated exocytosis through direct association with Syn4 in the absence of appropriate stimuli, which is relieved upon stimulus-induced calcium influx to activate gelsolin and induce its dissociation from Syn4 to facilitate insulin exocytosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22108804      PMCID: PMC3248323          DOI: 10.1210/me.2011-1112

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  73 in total

Review 1.  SNAREs--engines for membrane fusion.

Authors:  Reinhard Jahn; Richard H Scheller
Journal:  Nat Rev Mol Cell Biol       Date:  2006-08-16       Impact factor: 94.444

2.  Synaptotagmin VII splice variants alpha, beta, and delta are expressed in pancreatic beta-cells and regulate insulin exocytosis.

Authors:  Benoit R Gauthier; Dominique L Duhamel; Mariella Iezzi; Sten Theander; Frédéric Saltel; Mitsunori Fukuda; Bernhard Wehrle-Haller; Claes B Wollheim
Journal:  FASEB J       Date:  2007-08-20       Impact factor: 5.191

3.  Imaging exocytosis of single insulin secretory granules with evanescent wave microscopy: distinct behavior of granule motion in biphasic insulin release.

Authors:  Mica Ohara-Imaizumi; Yoko Nakamichi; Toshiaki Tanaka; Hitoshi Ishida; Shinya Nagamatsu
Journal:  J Biol Chem       Date:  2001-12-21       Impact factor: 5.157

4.  Pancreatic beta-cell web: its possible role in insulin secretion.

Authors:  L Orci; K H Gabbay; W J Malaisse
Journal:  Science       Date:  1972-03-10       Impact factor: 47.728

5.  Differential phosphorylation of RhoGDI mediates the distinct cycling of Cdc42 and Rac1 to regulate second-phase insulin secretion.

Authors:  Zhanxiang Wang; Debbie C Thurmond
Journal:  J Biol Chem       Date:  2009-12-22       Impact factor: 5.157

6.  Caveolin-1 functions as a novel Cdc42 guanine nucleotide dissociation inhibitor in pancreatic beta-cells.

Authors:  Angela K Nevins; Debbie C Thurmond
Journal:  J Biol Chem       Date:  2006-05-19       Impact factor: 5.157

7.  Identification of synaptic proteins and their isoform mRNAs in compartments of pancreatic endocrine cells.

Authors:  G Jacobsson; A J Bean; R H Scheller; L Juntti-Berggren; J T Deeney; P O Berggren; B Meister
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

8.  Pancreatic beta cell line MIN6 exhibits characteristics of glucose metabolism and glucose-stimulated insulin secretion similar to those of normal islets.

Authors:  H Ishihara; T Asano; K Tsukuda; H Katagiri; K Inukai; M Anai; M Kikuchi; Y Yazaki; J I Miyazaki; Y Oka
Journal:  Diabetologia       Date:  1993-11       Impact factor: 10.122

9.  Glucose regulates the cortical actin network through modulation of Cdc42 cycling to stimulate insulin secretion.

Authors:  Angela K Nevins; Debbie C Thurmond
Journal:  Am J Physiol Cell Physiol       Date:  2003-05-21       Impact factor: 4.249

10.  Impaired insulin secretion and glucose intolerance in synaptotagmin-7 null mutant mice.

Authors:  Natalia Gustavsson; Ye Lao; Anton Maximov; Jen-Chieh Chuang; Elena Kostromina; Joyce J Repa; Cai Li; George K Radda; Thomas C Südhof; Weiping Han
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-28       Impact factor: 11.205

View more
  28 in total

Review 1.  The good and bad effects of cysteine S-nitrosylation and tyrosine nitration upon insulin exocytosis: a balancing act.

Authors:  Dean A Wiseman; Debbie C Thurmond
Journal:  Curr Diabetes Rev       Date:  2012-07-01

2.  Neuron-enriched RNA-binding Proteins Regulate Pancreatic Beta Cell Function and Survival.

Authors:  Jonàs Juan-Mateu; Tatiana H Rech; Olatz Villate; Esther Lizarraga-Mollinedo; Anna Wendt; Jean-Valery Turatsinze; Letícia A Brondani; Tarlliza R Nardelli; Tatiane C Nogueira; Jonathan L S Esguerra; Maria Inês Alvelos; Piero Marchetti; Lena Eliasson; Décio L Eizirik
Journal:  J Biol Chem       Date:  2017-01-11       Impact factor: 5.157

3.  Sirtuin 6 regulates glucose-stimulated insulin secretion in mouse pancreatic beta cells.

Authors:  Xiwen Xiong; Gaihong Wang; Rongya Tao; Pengfei Wu; Tatsuyoshi Kono; Kevin Li; Wen-Xing Ding; Xin Tong; Sarah A Tersey; Robert A Harris; Raghavendra G Mirmira; Carmella Evans-Molina; X Charlie Dong
Journal:  Diabetologia       Date:  2016-01       Impact factor: 10.122

4.  Munc18-1 regulates first-phase insulin release by promoting granule docking to multiple syntaxin isoforms.

Authors:  Eunjin Oh; Michael A Kalwat; Min-Jung Kim; Matthijs Verhage; Debbie C Thurmond
Journal:  J Biol Chem       Date:  2012-06-08       Impact factor: 5.157

Review 5.  Exocytosis proteins as novel targets for diabetes prevention and/or remediation?

Authors:  Arianne Aslamy; Debbie C Thurmond
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-03-29       Impact factor: 3.619

6.  Interaction of Munc18c and syntaxin4 facilitates invadopodium formation and extracellular matrix invasion of tumor cells.

Authors:  Megan I Brasher; David M Martynowicz; Olivia R Grafinger; Andrea Hucik; Emma Shanks-Skinner; James Uniacke; Marc G Coppolino
Journal:  J Biol Chem       Date:  2017-08-10       Impact factor: 5.157

7.  A p21-activated kinase (PAK1) signaling cascade coordinately regulates F-actin remodeling and insulin granule exocytosis in pancreatic β cells.

Authors:  Michael A Kalwat; Stephanie M Yoder; Zhanxiang Wang; Debbie C Thurmond
Journal:  Biochem Pharmacol       Date:  2012-12-16       Impact factor: 5.858

Review 8.  Multiple roles for the actin cytoskeleton during regulated exocytosis.

Authors:  Natalie Porat-Shliom; Oleg Milberg; Andrius Masedunskas; Roberto Weigert
Journal:  Cell Mol Life Sci       Date:  2012-09-18       Impact factor: 9.261

9.  Doc2b serves as a scaffolding platform for concurrent binding of multiple Munc18 isoforms in pancreatic islet β-cells.

Authors:  Latha Ramalingam; Jingping Lu; Andy Hudmon; Debbie C Thurmond
Journal:  Biochem J       Date:  2014-12-01       Impact factor: 3.857

10.  Isoxazole Alters Metabolites and Gene Expression, Decreasing Proliferation and Promoting a Neuroendocrine Phenotype in β-Cells.

Authors:  Michael A Kalwat; Zhimin Huang; Chonlarat Wichaidit; Kathleen McGlynn; Svetlana Earnest; Claudia Savoia; Elhadji M Dioum; Jay W Schneider; Michele R Hutchison; Melanie H Cobb
Journal:  ACS Chem Biol       Date:  2016-02-10       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.